AU8679801A - Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions - Google Patents

Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions

Info

Publication number
AU8679801A
AU8679801A AU8679801A AU8679801A AU8679801A AU 8679801 A AU8679801 A AU 8679801A AU 8679801 A AU8679801 A AU 8679801A AU 8679801 A AU8679801 A AU 8679801A AU 8679801 A AU8679801 A AU 8679801A
Authority
AU
Australia
Prior art keywords
desmethylselegiline
conditions
methods
pharmaceutical compositions
neoplastic diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU8679801A
Inventor
Cheryl D Blume
Anthony R Disanto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Somerset Pharmaceuticals Inc
Original Assignee
Somerset Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somerset Pharmaceuticals Inc filed Critical Somerset Pharmaceuticals Inc
Publication of AU8679801A publication Critical patent/AU8679801A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU8679801A 2000-08-28 2001-08-27 Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions Pending AU8679801A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22843100P 2000-08-28 2000-08-28
PCT/US2001/026658 WO2002019964A2 (en) 2000-08-28 2001-08-27 Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions

Publications (1)

Publication Number Publication Date
AU8679801A true AU8679801A (en) 2002-03-22

Family

ID=22857139

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001286798A Ceased AU2001286798B2 (en) 2000-08-28 2001-08-27 Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions
AU8679801A Pending AU8679801A (en) 2000-08-28 2001-08-27 Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001286798A Ceased AU2001286798B2 (en) 2000-08-28 2001-08-27 Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions

Country Status (3)

Country Link
AU (2) AU2001286798B2 (en)
CA (1) CA2420993A1 (en)
WO (1) WO2002019964A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2349544T3 (en) 2005-02-18 2011-01-04 Universitätsklinikum Freiburg CONTROL OF THE DEPENDENT GENE EXPRESSION OF ANDROGEN RECEPTORS INHIBITING THE ACTIVITY OF AMINA OXIDASA OF THE LISINE-SPECIFIC DEMETILASE (LSD1).

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6299901B1 (en) * 1995-01-13 2001-10-09 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6319954B1 (en) * 1995-01-13 2001-11-20 Somerset Pharmaceuticals, Inc. S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
US6033682A (en) * 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
JP3036847B2 (en) * 1995-01-13 2000-04-24 サマーセット・ファーマシューティカルズ・インコーポレイテッド Method and pharmaceutical composition using desmethylselegiline
US6417160B1 (en) * 1997-10-14 2002-07-09 Nadine A. Tatton Methods for increasing schwann cell survival
ATE223209T1 (en) * 1998-01-13 2002-09-15 Univ Saskatchewan COMPOSITION CONTAINING PROPARGYLAMIN FOR IMPROVEMENT OF CANCER THERAPY
US20020137786A1 (en) * 1998-02-12 2002-09-26 William G. Tatton Deprenyl compounds to treat viral infections and reduce tissue damage associated therewith
BR9908713A (en) * 1998-03-16 2000-11-21 Somerset Pharmaceuticals Inc Use of selegiline or demethyl-selegiline to treat wounds, burns and dermatological damage

Also Published As

Publication number Publication date
WO2002019964A2 (en) 2002-03-14
CA2420993A1 (en) 2002-03-14
AU2001286798B2 (en) 2007-05-17
WO2002019964A3 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
IL162533A0 (en) Chalcone derivatives and their use to treat diseases
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
AU6147401A (en) Compositions and methods for the treatment of cancer
AU2002324914A1 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
EP1328284A4 (en) Novel medicinal herbal composition for treating liver diseases and hiv
MXPA02004770A (en) Therapeutic compositions and methods of use thereof.
GB0007193D0 (en) Treatment of movrmrnt disorders
HU0103078D0 (en) Pharmaceutical compositions and methods for treating cataracts
HRP20030874A2 (en) Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
MXPA03008634A (en) Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases.
HUP0302718A3 (en) Methods and compositions for the treatment of diseases of the eye
AU2002237667A1 (en) Methods for the treatment and prevention of urinary stone disease
AU2002235692A1 (en) Methods and compositions for preventing and treating neutrophil-mediated diseases
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
IL153487A0 (en) Pharmaceutical compositions and methods for use
HUP0301553A3 (en) Pharmaceutical compositions and their use for treating neurological disorders
IL153897A0 (en) Pharmaceutical compositions and methods for use
AU2001232345A1 (en) Compositions for preventing and treating digestive diseases
AU8679801A (en) Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases
GB2381455B (en) Treatment of burns
IL154168A0 (en) Improved specificity in treatment of diseases
GB0007217D0 (en) Materials and methods relating to the treatment of leukaemias